Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

Autor:	Hodgson, Robert A.1 Robert.Hodgson@Merck.com, Bedard, Paul J.2, Varty, Geoffrey B.1, Kazdoba, Tatiana M.1, Di Paolo, Therese3, Grzelak, Michael E.1, Pond, Annamarie J.1, HadjTahar, Abdallah2, Belanger, Nancy2, Gregoire, Laurent2,3, Dare, Aurelie2, Neustadt, Bernard R.4, Stamford, Andrew W.4, Hunter, John C.5
Zdroj:	Experimental Neurology. Oct2010, Vol. 225 Issue 2, p384-390. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect